Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & working
1.3 Data collection
1.4 Base estimates & workings
1.5 Forecast calculations
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global prostate-specific antigen test market 3600 synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Test type trends
2.1.4 Application trends
2.1.5 End-use trends
Chapter 3 Prostate-Specific Antigen Test Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing incidence of prostate cancer
3.2.1.2 Growing geriatric population
3.2.1.3 Technological advancements in PSA testing
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of PSA testing
3.3 Growth potential analysis
3.3.1 By test type
3.3.2 By application
3.3.3 By end-use
3.4 COVID- 19 impact analysis
3.5 Technology landscape
3.6 Regulatory landscape
3.7 Reimbursement scenario
3.8 Gap analysis
3.9 Porter's analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Vendor matrix analysis, 2022
4.6 Strategy dashboard, 2022
Chapter 5 Prostate-Specific Antigen Test Market Size and Forecast, By Test Type, 2018-2032 (USD Million)
5.1 Key trends, by test type
5.2 Preliminary tests
5.2.1 Total prostate specific antigen test
5.2.2 Complex prostate specific antigen test
5.2.3 Free prostate specific antigen test
5.3 Confirmatory tests
5.3.1 PCA3 test
5.3.2 Trans-rectal ultrasound
5.3.3 Biopsy
Chapter 6 Prostate-Specific Antigen Test Market Size and Forecast, By Application, 2018-2032 (USD Million)
6.1 Key trends, by application
6.2 Prostate cancer screening
6.3 Prostate cancer monitoring
Chapter 7 Prostate-Specific Antigen Test Market Size and Forecast, By End-use, 2018-2032 (USD Million)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Diagnostic centers
7.4 Specialty clinics
7.5 Other end-users
Chapter 8 Prostate-Specific Antigen Test Market Size and Forecast, By Region, 2018-2032 (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 Abbott Laboratories Inc.
9.2 AdvaCare Pharma
9.3 Bayer AG
9.4 Bio-Rad Laboratories, Inc.
9.5 Beckman Coulter, Inc.
9.6 FUJIREBIO is an H.U. Group company.
9.7 GE HealthCare.
9.8 Abcam plc.
9.9 Lomina AG.
9.10 Laboratory Corporation of America Holdings
